Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06650488
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-18
Brief Title:
Clopidogrel Vs Aspirin in Patients with S Aureus Bacteremia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Clopidogrel Vs Aspirin in Patients with S Aureus Bacteremia Clopido-SNAP
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Clopido-SNAP
Brief Summary:
This is an open-label randomized controlled trial which will enroll patients with S aureus bacteremia who are already taking aspirin for secondary prevention of cardiovascular events We will randomize patients to continue their aspirin or change clopidogrel which is also approved for secondary prevention
Unlike aspirin clopidogrel may have activity against S aureus We wish to determine if changing to clopidogrel will improve outcomes in S aureus bacteremia in people who otherwise would have a reason to be taking it
This study is an approved sub-study of The Staphylococcus aureus Network Adaptive Platform SNAP trial NCT05137119
If positive this study will support a second RCT in people who do not currently have an indication for clopidogrel
Unlike aspirin clopidogrel may have activity against S aureus We wish to determine if changing to clopidogrel will improve outcomes in S aureus bacteremia in people who otherwise would have a reason to be taking it
This study is an approved sub-study of The Staphylococcus aureus Network Adaptive Platform SNAP trial NCT05137119
If positive this study will support a second RCT in people who do not currently have an indication for clopidogrel
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None